Superstock Investor
Member Login   RSS ->
James DiGeorgia, Mr. Macro
- Chief Editor -
Mr. Macro
Geoff Garbacz, Mr. Micro
- Chief Strategist -
Mr. Micro
Dan Hassey, Mr. Retirement
- Senior Stock Analyst -
Mr. Retirement
Superstock Investor


[Printable Version of This Page]

Today's Superstock Investor Stock Scorecard:

BRISTOL-MYERS SQUIBB CO (BMY)
by Superstock Investor

June 19, 2018

 

Bristol Myers (BMY) has fallen since we removed it from our Morning Matters Portfolio. The stock hit $50 and is now at $53.65. Is it worth a shot here?

Company Information

Company: BRISTOL-MYERS SQUIBB CO
Sector: Pharmaceuticals
Industry: Pharmaceuticals
Market Cap:  $105,100 (Millions)

Targets

  Price %Gain  
Current Price $59.98    
Price Target $57.41 -4.3%  
Upper Bound $69.77 16.3%  
Lower Bound $48.67 -18.9%  

Fundamental Variables

P/E Ratio 23.4    
Sales Growth -2.1%    

Valuation Variables

  Past Current Future
Profitability (CFROI) 15.4% 12.5% 9.6%
Growth (in Assets) 5.1% 3.9% 3.8%
 
Color Legend
Company
Rating
Company
Rank
Excellent Top 10%
Good 11- 30%
Average 31- 70%
Fair 71- 90%
Poor Bottom 10%

Stock data last updated 01/10/2017.

Data provided by QPI, Inc. All information provided "as is" for informational purposes only, not intended for trading purposes or advice. QPI, Inc. is not liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing this page, you agree not to redistribute the information found herein.

Stock Scorecard Archives